MOPH

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
R03AC02	BUTALIN	G	Salbutamol (sulfate) - 100mcg/dose	100mcg/dose	Inhalation aerosol metered dose	145,135 L.L
R03AL11	BREZTRI AEROSPHERE	B	Formoterol fumarate dihydrate - 5mcg, Glycopyrronium Bromide - 7.2mcg, Budesonide - 160mcg		Inhalation suspension	6,705,774 L.L
R03BA02	BUDENA	G	Budesonide - 50mcg/actuation	50mcg/actuation	Inhalation suspension	823,775 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 1mg/2ml	1mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 1mg/2ml	1mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 0.5mg/2ml	0.5mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 0.5mg/2ml	0.5mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L
L01FF04	BAVENCIO	BioTech	Avelumab - 200mg/10ml	200mg/10ml	Injectable concentrate for solution	L.L
C01BG11	BRINAVESS	B	Vernakalant - 20mg/ml	20mg/ml	Injectable concentrate for solution	41,821,582 L.L
J01MA23	BAXDELA	B	Delafloxacin - 300mg	300mg	Injectable concentrate for solution	78,349,010 L.L
L01FF04	BAVENCIO	BioTech	Avelumab - 200mg/10ml	200mg/10ml	Injectable concentrate for solution	94,771,465 L.L
L01FG01	BIVASTINA 400	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	142,487,946 L.L
L01FG01	BIVASTINA 400	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	77,844,379 L.L
L01FG01	BIVASTINA 100	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	18,490,076 L.L
L01FG01	BIVASTINA 100	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	47,495,416 L.L
M05BA06	BONDRONAT	B	Ibandronic acid (monosodium monohydrate) - 6mg/6ml	6mg/6ml	Injectable concentrated powder for solution	24,963,868 L.L
L01AA09	BENDAVIVAL	G	Bendamustine HCl - 100mg	100mg	Injectable concentrated powder for solution	26,072,618 L.L
B03BA51	BETOLVEX	B	Aluminium monostearate - 20mg/ml, Cyanocobalamine - 1mg/ml		Injectable emulsion	423,310 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	21,602,799 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	21,602,799 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	35,076,021 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,270,499 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	25,895,605 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 1,000IU	1,000IU	Injectable lyophilised powder for solution+diluent	44,948,602 L.L
L01FX07	BLINCYTO	BioTech	Blinatumomab - 35mcg	35mcg	Injectable lyophilised powder for solution+stabilizer	239,484,334 L.L
L01AA09	BENDAMUSTINE HYDROCHLORIDE ACCORD	G	Bendamustine HCl - 25mg/10ml	25mg/10ml	Injectable powder for concentrate for solution	19,610,153 L.L
L01AA09	BENDAMUSTINE MEDAC	G	Bendamustine HCl - 2.5mg/ml (25mg)	2.5mg/ml	Injectable powder for concentrate for solution	25,099,310 L.L
L01AA09	BENDAMUSTINE HYDROCHLORIDE	G	Bendamustine HCl - 100mg/50ml	100mg/50ml	Injectable powder for concentrate for solution	78,439,178 L.L
L01AA09	BENDAMUSTINE MEDAC	G	Bendamustine HCl - 2.5mg/ml (100mg)	2.5mg/ml	Injectable powder for concentrate for solution	16,999,467 L.L